Literature DB >> 25164114

Micro RNAs: the future of idiopathic pulmonary fibrosis therapy.

Tara Vinyette Saco1, Prasanna Tamarapu Parthasarathy, Young Cho, Richard Lockey, Narasaiah Kolliputi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25164114      PMCID： PMC4291287          DOI： 10.1007/s12013-014-0217-9

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN： 1085-9195            Impact factor:   2.194


× No keyword cloud information.
  9 in total

Review 1.  Idiopathic pulmonary fibrosis: diagnosis and epidemiology.

Authors:  Amy L Olson; Jeffrey J Swigris
Journal:  Clin Chest Med       Date:  2012-03       Impact factor: 2.878

Review 2.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

3.  Methylation determines fibroblast activation and fibrogenesis in the kidney.

Authors:  Wibke Bechtel; Scott McGoohan; Elisabeth M Zeisberg; Gerhard A Müller; Hubert Kalbacher; David J Salant; Claudia A Müller; Raghu Kalluri; Michael Zeisberg
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

4.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells.

Authors:  Yun Lu; J Michael Thomson; Ho Yuen Frank Wong; Scott M Hammond; Brigid L M Hogan
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

5.  miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Jadranka Milosevic; Qiang Ding; Victor J Thannickal; Naftali Kaminski; Edward Abraham
Journal:  J Exp Med       Date:  2010-07-19       Impact factor: 14.307

6.  A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets.

Authors:  Gerard J Nuovo; Terry S Elton; Patrick Nana-Sinkam; Stefano Volinia; Carlo M Croce; Thomas D Schmittgen
Journal:  Nat Protoc       Date:  2009-01-08       Impact factor: 13.491

7.  Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis.

Authors:  Duaa Dakhlallah; Kara Batte; Yijie Wang; Carmen Z Cantemir-Stone; Pearlly Yan; Gerard Nuovo; Adel Mikhail; Charles L Hitchcock; Valerie P Wright; S Patrick Nana-Sinkam; Melissa G Piper; Clay B Marsh
Journal:  Am J Respir Crit Care Med       Date:  2013-01-10       Impact factor: 21.405

8.  Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes.

Authors:  Ji-Hoon Cho; Richard Gelinas; Kai Wang; Alton Etheridge; Melissa G Piper; Kara Batte; Duaa Dakhallah; Jennifer Price; Dan Bornman; Shile Zhang; Clay Marsh; David Galas
Journal:  BMC Med Genomics       Date:  2011-01-17       Impact factor: 3.063

9.  Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.

Authors:  Andrea Ventura; Amanda G Young; Monte M Winslow; Laura Lintault; Alex Meissner; Stefan J Erkeland; Jamie Newman; Roderick T Bronson; Denise Crowley; James R Stone; Rudolf Jaenisch; Phillip A Sharp; Tyler Jacks
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582
  9 in total
  2 in total

1.  miR-21 Exerts Anti-proliferative and Pro-apoptotic Effects in LPS-induced WI-38 Cells via Directly Targeting TIMP3.

Authors:  Jin-Xiu Li; You Li; Tian Xia; Feng-Yan Rong
Journal:  Cell Biochem Biophys       Date:  2021-05-03       Impact factor: 2.194

2.  Amelioration of paraquat-induced pulmonary fibrosis in mice by regulating miR-140-5p expression with the fibrogenic inhibitor Xuebijing.

Authors:  Min-Na Dong; Yun Xiao; Yun-Fei Li; Dong-Mei Wang; Ya-Ping Qu; Tian-Wen Fang; Hui Li; Ming-Wei Liu
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.